Corporate Banner
Satellite Banner
Scientific Community
Join | Sign in

  News Archive

Takeda Licenses Rights to Use ImmunoGen's ADC Technology
Friday, March 27, 2015
To develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets.

AbbVie and C2N Enter into a Worldwide License Agreement
Friday, March 27, 2015
License agreement to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease.

MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration
Friday, March 27, 2015
MorphoSys regains rights to MOR202 antibody against CD38 and updates its financial guidance for 2015.

Compugen Announces Planned Relocation of Headquarters to Larger Facilities
Wednesday, March 25, 2015
New facilities double available space for corporate offices and research and discovery in Israel.

Celldex Announces Clinical Trial Collaboration with Roche
Friday, March 20, 2015
Collaboration to evaluate the combination of varlilumab and MPDL3280A.

WuXi PharmaTech to Build New Cell Therapy Manufacturing Facility
Friday, March 20, 2015
Facility is designed for CAR T cells and other cancer immunotherapies.

Strengthening the Immune System’s Fight Against Brain Cancer
Friday, March 20, 2015
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors.

Key TxCell Patent to be Granted in the US for its Lead Product Ovasave®
Thursday, March 19, 2015
Patent ensures protection for Ovasave® in the US until 2030 minimum.

Surprising Finding In Stroke Research
Wednesday, March 18, 2015
Scientists at The University of Manchester have made an important new discovery about the brain’s immune system that could lead to potential new treatments for stroke and other related conditions.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1362

SELECTBIO Market Reports
Go to LabTube
Go to eposters